Sign up
Quantellect · Analysts · Analyst Profile
Analyst Score Rank#287 of 589

Chris Schott

JP Morgan · Equity Research Analyst
ProvisionalRating since 2018No new ratings since Nov 2025

Analyst rating accuracy & track record

Chris Schott is an equity research analyst at JP Morgan. Quantellect has scored 21 of their stock calls across 11 companies. Their picks beat their sector 41% of the time over the next 12 months, and their price targets were reached 50% of the time within a year.

Win % vs sector
41%
PT Hit % (12mo)
50%
Avg sector-excess
−4.6%
Scored calls
21
Tickers
11
Tier
Provisional

Track record

Quantellect has scored 21 of Chris Schott's stock calls across 11 companies, dating back to 2018. Their rated stocks beat their own sector 41% of the time over the next 12 months. On a typical call, a Schott pick returned −4.6% more than its sector over the following year.

Of the scored calls, 19 were bullish (Buy) and 2 were bearish (Sell). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
OGNOrganon & Co
Sell$12.00Nov 2025−56.7%Hit
TEVATeva Pharma Industries Ltd ADR
Buy$28.00Nov 2025+50.2%Hit
ZTSZoetis Inc
Buy$200.00Nov 2025−58.5%Miss
IDXXIDEXX Laboratories Inc
Buy$775.00Nov 2025−34.3%Miss
IDXXIDEXX Laboratories Inc
Buy$775.00Nov 2025−34.8%Miss
ABBVAbbVie Inc
Buy$260.00Nov 2025+6.8%Hit
IDXXIDEXX Laboratories Inc
Buy$775.00Nov 2025−34.8%Miss
GILDGilead Sciences Inc
Buy$150.00Oct 2025+12.4%Hit
ELANElanco Animal Health
Buy$24.00Oct 2025−7.9%Hit
TEVATeva Pharma Industries Ltd ADR
Buy$26.00Oct 2025+81.6%Hit
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock
Buy$14.00Sep 2025+64.7%Hit
PRGOPerrigo Company PLC
Buy$35.00Aug 2025−67.1%Miss
IDXXIDEXX Laboratories Inc
Buy$675.00Aug 2025−32.3%Hit
TEVATeva Pharma Industries Ltd ADR
Buy$23.00May 2025+92.3%Hit
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock
Buy$12.00Feb 2025+64.6%Hit
OGNOrganon & Co
Sell$20.00Sep 2024+36.4%Hit
PRGOPerrigo Company PLC
Buy$41.00Feb 2024−7.7%Miss
RPRXRoyalty Pharma Plc
Buy$42.00Feb 2024+4.6%Miss
PRGOPerrigo Company PLC
Buy$48.00Aug 2023−37.3%Miss
RPRXRoyalty Pharma Plc
Buy$52.00Oct 2022−37.3%Miss
KALAKala Pharmaceuticals Inc
Buy$22.00Nov 2018−51.9%Miss
Prev1Next
Go to

Chris Schott: analyst track record FAQ

Is Chris Schott a good stock analyst?

Yes, by track record. Chris Schott ranks number 287 of 589 of the analysts Quantellect scores, with an Analyst Score of 36 out of 100. Past results do not guarantee future ones.

What is Chris Schott's win rate?

Chris Schott's win rate is 41%. Across 21 scored calls, their rated stocks beat their sector 41% of the time over the next 12 months. On a typical call they returned −4.6% more than the sector.

What stocks and sectors does Chris Schott cover?

Chris Schott covers 11 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Chris Schott's price targets accurate?

Chris Schott's price targets are reached within 12 months 50% of the time. The base rate across all analysts Quantellect tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Quantellect scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Chris Schott's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Quantellect score analyst accuracy?

Quantellect scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Chris Schott rank among Wall Street analysts?

Chris Schott ranks number 287 of 589 by Analyst Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Quantellect calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.